En
  • En English
  • De Deutsch
  • Fr Français
  • Sp Español
  • Ru Русский
  • It Italiano
  • Pt Português
  • Ua Українська
22 results

    OrientationOrientation
    PeoplePeople
    CategoryCategory
    ColorColor
    EditorialEditorial
    Safe SearchSafe Search
    Clear
    Hide
    Molecular model of pink mdm2 protein binding to anti-cancer protein p53. — Stock Photo
    Molecular model of pink mdm2 protein binding to anti-cancer protein p53.
    Molecular model of the anti-cancer protein p53. — Stock Photo
    Molecular model of the anti-cancer protein p53.
    Destruction of cancer cell — Stock Photo
    Destruction of cancer cell
    Destruction of cancer cell — Stock Photo
    Destruction of cancer cell
    Pink molecular model of DNA binding to anti-cancer protein p53. — Stock Photo
    Pink molecular model of DNA binding to anti-cancer protein p53.
    Active CAR T-cells cancer immunotherapy, medical illustration. — Stock Photo
    Active CAR T-cells cancer immunotherapy, medical illustration.
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer — Stock Photo
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer
    Destruction of cancer cell, digital conceptual illustration illustrating treatment of cancer by drugs, nanoparticles and antibodies. — Stock Photo
    Destruction of cancer cell, digital conceptual illustration illustrating treatment of cancer by drugs, nanoparticles and antibodies.
    Destruction of a cancer cell by antibodies — Stock Photo
    Destruction of a cancer cell by antibodies
    Destruction of cancer cell, digital conceptual illustration illustrating treatment of cancer by drugs, nanoparticles and antibodies. — Stock Photo
    Destruction of cancer cell, digital conceptual illustration illustrating treatment of cancer by drugs, nanoparticles and antibodies.
    Pink molecular model of DNA binding to anti-cancer protein p53. — Stock Photo
    Pink molecular model of DNA binding to anti-cancer protein p53.
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer — Stock Photo
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer
    Destruction of cancer cell, digital conceptual illustration illustrating treatment of cancer by drugs, nanoparticles and antibodies. — Stock Photo
    Destruction of cancer cell, digital conceptual illustration illustrating treatment of cancer by drugs, nanoparticles and antibodies.
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer — Stock Photo
    Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, process that is being developed to treat cancer
    Destruction of a cancer cell by antibodies — Stock Photo
    Destruction of a cancer cell by antibodies
    Destruction of cancer cell — Stock Photo
    Destruction of cancer cell
    Active CAR T-cells cancer immunotherapy, medical illustration. — Stock Photo
    Active CAR T-cells cancer immunotherapy, medical illustration.
    Nurse comforting female chemotherapy patient. — Stock Photo
    Nurse comforting female chemotherapy patient.
    Active CAR T-cells cancer immunotherapy, medical illustration. — Stock Photo
    Active CAR T-cells cancer immunotherapy, medical illustration.
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment. — Stock Photo
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment.
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment. — Stock Photo
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment.
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment. — Stock Photo
    Illustration of CAR DNA modified T-cell immunotherapy process for cancer treatment.